Europe Ultrasound Devices Market Size, Share & Forecast (2025–2033) – Renub Research
Market Overview
The Europe Ultrasound Devices Market was valued at USD 2.53 billion in 2024 and is projected to reach USD 4.04 billion by 2033, expanding at a CAGR of 5.32% during the forecast period (2025–2033). The market’s upward trajectory is driven by increasing demand for non-invasive diagnostic technologies, advancements in ultrasound imaging, rising healthcare spending, and a growing prevalence of chronic diseases across European nations.
Ultrasound devices are integral to modern medical diagnostics, providing real-time, radiation-free imaging for a wide array of applications—from prenatal screening and cardiac assessments to musculoskeletal evaluations and oncological diagnostics.
What Is Driving the Growth of the Europe Ultrasound Devices Market?
1. Technological Advancements in Ultrasound Imaging
The integration of 3D/4D imaging, AI-powered diagnostic algorithms, and High-Intensity Focused Ultrasound (HIFU) has significantly enhanced image quality, diagnostic accuracy, and usability of ultrasound devices. Companies are rapidly introducing portable and handheld ultrasound solutions that offer mobility and convenience in emergency settings, home healthcare, and rural diagnostics.
Noteworthy Development:
In September 2024, French firm Sonio received CE certification for Sonio Detect, an AI-driven fetal ultrasound reporting solution, signifying a step toward smarter, automated diagnostics in Europe.
2. Rising Prevalence of Chronic and Lifestyle Diseases
The surge in cardiovascular diseases, cancer, renal disorders, and other chronic conditions has amplified the demand for early, cost-effective, and non-invasive diagnostic modalities like ultrasound. According to the European Commission, over 318,000 new lung cancer cases were reported in 2020—highlighting the urgency for robust diagnostic infrastructure.
3. Favorable Government Policies and Healthcare Investments
Governments across Europe—especially in Germany, France, and the UK—are boosting public health spending and infrastructure upgrades. Incentives for early disease detection and telemedicine are stimulating wider ultrasound device deployment in both urban and remote healthcare setups.
Stat Highlight:
As per Eurostat (2022), 7.7% of the region’s GDP, equivalent to USD 1,334.7 billion, was spent on healthcare, indicating strong institutional support for technological adoption.
Key Market Challenges
1. High Costs of Advanced Equipment
Despite advancements, cutting-edge systems such as 3D/4D and HIFU devices are expensive. The high upfront investment, coupled with maintenance and training costs, can deter small and mid-size clinics from upgrading their equipment.
2. Shortage of Skilled Technicians
There is a notable gap in the availability of trained sonographers and radiologists in Europe. Lack of skilled personnel limits the efficient usage of advanced ultrasound technologies, leading to diagnostic delays and potential inaccuracies.
Segmental Analysis of Europe Ultrasound Devices Market
By Application
Cardiology:
Rising cardiovascular conditions are fueling demand for echocardiography tools that allow real-time heart imaging for detecting valve dysfunctions and blockages.
Anesthesiology:
Used for guiding nerve blocks and regional anesthesia, ultrasound enhances procedural safety and precision in surgeries.
Gynecology/Obstetrics:
The sector heavily uses 3D and 4D ultrasound imaging for fetal monitoring and reproductive diagnostics.
Musculoskeletal & Vascular:
Ultrasound plays a vital role in detecting soft tissue injuries, thrombosis, and vascular abnormalities.
New Publish Reports
Ultrasound Devices Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033
By Technology
2D Ultrasound Imaging
3D and 4D Imaging
Doppler Imaging
High-Intensity Focused Ultrasound (HIFU)
3D/4D imaging is seeing rapid uptake due to enhanced visualization and patient demand for advanced diagnostics. HIFU is gaining traction in cancer treatment and fibroid therapy due to its non-invasive nature.
By Type
Stationary Ultrasound Systems
Portable Ultrasound Devices
The portable segment is booming thanks to increasing point-of-care diagnostics in emergency, sports, and home-based care settings. AI-integrated, wireless, and mobile units are particularly popular.
By End User
Hospitals
Diagnostic Centers
Other End Users
Diagnostic centers are emerging as major contributors due to their specialized nature and high footfall, especially in urban regions.
Country-Wise Market Insights
Germany
Germany remains a powerhouse in the European ultrasound market due to its high-tech healthcare ecosystem and advanced research infrastructure. In March 2024, Insighttec gained NUB Status 1 for its MRgFUS treatment for essential tremors, enabling broader access to cutting-edge therapies.
France
Governmental healthcare reforms and local manufacturing capacity are boosting the French ultrasound market. In December 2022, Siemens Healthineers launched its first European ultrasound factory in France with a weekly capacity of 120 units.
United Kingdom
The NHS’s emphasis on early diagnosis and preventive care is fueling ultrasound equipment demand. In May 2022, Clarius Mobile Health introduced portable wireless scanners, compatible with iOS and Android, revolutionizing mobile diagnostics.
Russia
Russia’s market is growing due to government-backed modernization and local production. In 2022, Glavkosmos JSC announced the international rollout of RuSkan ultrasound systems, made by NPO Scanner, expanding domestic and global access.
Leading Companies in the Europe Ultrasound Devices Market
The market includes prominent global and regional players:
Fujifilm Holdings Corporation
GE Healthcare
Hitachi Medical Corporation
Philips Healthcare
Samsung
Siemens Healthcare
Canon Medical Systems Corporation
Mindray Medical International Limited
Company analysis includes:
Company Overview
Key Executives
Recent Developments
Product Portfolio
Revenue Insights
Europe Ultrasound Device Market – Segmentation Summary
| Segment | Sub-Segments |
| Application | Anesthesiology, Cardiology, Gynecology/Obstetrics, Musculoskeletal, Vascular, Others |
| Technology | 2D, 3D & 4D, Doppler, HIFU |
| Type | Stationary, Portable |
| End User | Hospitals, Diagnostic Centers, Others |
| Countries | France, Germany, UK, Italy, Spain, Russia, Poland, Greece, Belgium, Norway, Romania, Netherlands, Portugal, RoE |
Customization & Support
We offer up to 20% free customization, including:
Additional country or regional insights
Extended company profiling
Trade & production analysis
Custom market entry strategies
Post-sale analyst support: 1 year
Purchase Options
| License Type | Price |
| Dashboard (Excel) | $2,490 |
| Single User (PDF) | $2,990 |
| Five Users + Excel | $3,490 |
| Corporate License | $3,990 |
About Renub Research
Renub Research is a premier global research and consulting firm with 15+ years of expertise in delivering comprehensive B2B reports and actionable insights across healthcare, technology, food, energy, and emerging industries.
Contact Us: 📞 USA: +1-478-202-3244
📞 India: +91-120-421-9822
📧 Email: info@renub.com
🌐 Website: www.renub.com
